https://www.selleckchem.com/pr....oducts/epacadostat-i
About 41 (82%) patients had no history of hepatitis B vaccination series before starting hemodialysis; 36 (72%) had anti-hepatitis B surface antibody titre 10 mIU/ml. About 44 (88%) patients received a blood transfusion during their hemodialysis sessions and 14 (28%) patients had a history of receiving hemodialysis at other centres. Our study demonstrated a high prevalence of occult hepatitis B infection among end-stage renal disease patients starting hemodialysis. Our study demonstrated a high prevalence of occult he
Beğen
Yorum Yap
Paylaş
